Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Alina M. Mateo"'
Autor:
Alina M. Mateo, Elizabeth Handorf, Allison A. Aggon, Lyudmila DeMora, Elin R. Sigurdson, John M. Daly, Anna M. Mazor, Richard J. Bleicher, Elias Obeid
Publikováno v:
Ann Surg Oncol
Characterization of breast cancer phenotypes has improved our ability to predict breast cancer behavior. Triple-negative (TN) breast cancers have higher and earlier rates of distant events. It has been suggested that this behavior necessitates treati
Autor:
Allison A. Aggon, Elias Obeid, Shelly B. Hayes, Lyudmila DeMora, Richard J. Bleicher, Anna M. Mazor, Elin R. Sigurdson, John M. Daly, Elizabeth Handorf, Alina M. Mateo
Publikováno v:
Clin Breast Cancer
BACKGROUND: The management of small skin-involved (SI) invasive breast cancers is controversial because, although considered “unresectable,” prior data shows that their prognosis is far better than their Stage III classification. This study was u
Autor:
Alexa R. Carollo, Callum R. Douglass, Anna C. Curtis, Dmitry Baranov, David M. Jonas, Michael J. Lynch, Alina M. Mateo-Tejada
Publikováno v:
Chemistry of Materials. 31:1223-1230
Oleylamine is widely used in nanomaterial and metal-halide perovskite synthesis. Impurities in commercially available oleylamine reagents are identified, purification procedures are explained, beneficial effects on lead chloride/oleylamine mixtures a
Autor:
Lyudmila DeMora, Alina M. Mateo, Allison A. Aggon, John M. Daly, Elizabeth Handorf, Stephanie E. Weiss, Elin R. Sigurdson, Penny R. Anderson, Anna M. Mazor, Richard J. Bleicher
Publikováno v:
Breast Cancer Research and Treatment. 173:301-311
PURPOSE: Breast conservation therapy (BCT) is standard for T1-T2 tumors, but early trials excluded breast cancers >5 cm. This study was performed to assess patterns and outcomes of BCT for T3 tumors. METHODS: We reviewed the National Cancer Database
Autor:
Christopher M. Pezzi, V. Suzanne Klimberg, Alina M. Mateo, Todd A. Pezzi, Mark L. Sundermeyer, Cynthia A. Kelley
Publikováno v:
Annals of Surgical Oncology. 24:1050-1056
Medullary breast cancer (MBC) is a rare tumor associated with a better prognosis compared with other breast cancers. The role of adjuvant chemotherapy has not been extensively studied.Female patients with invasive MBC reported to the National Cancer
Autor:
Alina M. Mateo, Vicki Klimberg, Todd A. Pezzi, Christopher M. Pezzi, Mark L. Sundermeyer, Cynthia A. Kelley
Publikováno v:
Journal of Surgical Oncology. 114:533-536
Backgrounds and Objectives Medullary breast carcinoma (MBC) is a subtype with a more favorable prognosis. Tumors with some, but not all, characteristics of MBC are classified as atypical medullary carcinoma of the breast (AMCB). Methods Patients with
Autor:
Alina M, Mateo, Todd A, Pezzi, Mark, Sundermeyer, Cynthia A, Kelley, Vicki S, Klimberg, Christopher M, Pezzi
Publikováno v:
Journal of surgical oncology. 114(5)
Medullary breast carcinoma (MBC) is a subtype with a more favorable prognosis. Tumors with some, but not all, characteristics of MBC are classified as atypical medullary carcinoma of the breast (AMCB).Patients with invasive MBC and AMCB reported to t
Autor:
Alina M, Mateo, Arthur M, Frankel
Publikováno v:
The American surgeon. 81(12)
A retrospective study of 786 patients was conducted to determine the necessity of a 6-month interval study after a benign stereotactic or ultrasound-guided breast biopsy. These results were compared with those of other centers. After reviewing the da
Autor:
Christopher M. Pezzi, V. Suzanne Klimberg, Todd A. Pezzi, Mark L. Sundermeyer, Cynthia A. Kelley, Alina M. Mateo
Publikováno v:
Journal of Clinical Oncology. 34:1022-1022
1022Background: Medullary breast cancer (MBC) is a rare tumor associated with a better prognosis. The role of adjuvant chemotherapy has not been extensively studied. Methods: Female patients with i...